Article
Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein.
PLoS pathogens - 1 Aug 2023
Tong Tommy, D'Addabbo Alessio, Xu Jiamin, Chawla Himanshi, Nguyen Albert, Ochoa Paola, Crispin Max, Binley James M
Abstract excerpt
Recent HIV-1 vaccine development has centered on "near native" soluble envelope glycoprotein (Env) trimers that are artificially stabilized laterally (between protomers) and apically (between gp120 and gp41). These mutations have been leveraged for use in membrane-expressed Env mRNA vaccines, although their effects in this context are unclear. To address this question, we used virus-like particle (VLP) produced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
